The Children's Hospital of Philadelphia was awarded $38.9 million to advance gene‑editing therapies for hemophilia A and ...

Factor VIII (FVIII) replacement therapy is a cornerstone of treatment for many people with hemophilia A, a rare bleeding disorder caused by deficient or dysfunctional FVIII, a protein needed for blood ...

Recognition of hemophilia in women and girls is better, but challenges remain in getting accurate diagnoses and proper care, ...

Columnist Allyx Formalejo offers a meditation on the path toward finding balance in a relationship in the midst of difficult ...

Columnist Jennifer Lynne shares how she addresses chronic pain and structural damage from her various bleeding disorders.

Experimental treatment denecimig maintained low bleed rates in hemophilia A, with safety findings consistent with earlier ...

It can be easy to judge people whose illness is invisible, says columnist Cazandra Campos-MacDonald, but let's try to show empathy instead.

Early genetic testing done during IVF may be an option to help couples affected by hemophilia have healthy babies, a 10-year ...

Columnist Allyx Formalejo writes how living with her husband's hemophilia changed her relationship with the goals she had set ...

Columnist Jennifer Lynne says MASAC guidelines on screening for iron deficiency may be a game-changer for people with bleeding disorders.

The Haemophilia Joint Health Score (HJHS) may underestimate joint damage in women with hemophilia. This occurs because the tool uses male-specific joint mobility reference values. Using ...